3 ISA Buys With Big Growth Potential? GlaxoSmithKline plc, easyJet plc, And SKY PLC

Will GlaxoSmithKline plc (LON:GSK), easyJet plc (LON:EZJ) and SKY PLC (LON:SKY) boost your ISA profits next year?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

With only two more trading days left until the end of the tax year, it’s not too late to top up your ISA with some high-quality dividend growth stocks. In today’s article I’ll look at three major companies and ask whether these big cap stocks have the potential to deliver big growth.

An unbeatable buy?

GlaxoSmithKline (LSE: GSK) is one of the largest holdings in my personal portfolio, so I may be biased. But I don’t think I’m wrong.

The UK’s largest pharma stock has now completed a restructuring programme which saw it generate £2bn of sales from new products last year. That total is expected to reach £6bn by 2018. Alongside this, Glaxo expects to deliver £3bn of annual cost savings by 2017.

The result should be a leaner business with improved growth potential. The company will also get a new chief executive in March 2017, when current boss Sir Andrew Witty is set to retire.

In the meantime, Glaxo’s 80p per share dividend gives a yield of 5.7%. Net debt has fallen and earnings are expected to rise this year, making Glaxo’s generous dividend look more affordable than it did last year. In my view, now could be a very good time to build a long-term holding in GlaxoSmithKline.

Flying high, but for how long?

Shares in budget airline easyJet (LSE: EZJ) have fallen by 13% so far this year and by 20% over the last twelve months. The falls have come despite the group reporting rising passenger numbers, stable sales and rising profits.

easyJet’s adjusted earnings per share are expected to rise by 7% this year to 148.4p. This puts the stock on a forecast P/E of 10. There’s also an attractive 65.6p forecast dividend, giving a potential yield of 4.3%.

Current forecasts suggest that earnings growth will accelerate in 2017. Analysts have pencilled in a solid 15% rise in earnings to 170.7p per share.

So why does easyJet seem to be so cheap? One reason is that the airline industry is notoriously cyclical. easyJet shares have risen by 320% over the last five years, during which profits have more than doubled.  It may be that the market is pricing in a slowdown in this rate of growth. Other airline shares have also cooled this year.

However, easyJet’s valuation doesn’t seem demanding. The low-cost model seems to be here to stay. I’m tempted to say that at around 1,500p, easyJet could be a profitable buy.

An uncertain picture

Between October and December 2015, a whopping 337,000 new customers joined Sky (LSE: SKY), the highest level of UK and Ireland growth for ten years.

However, this influx of new customers isn’t expected to result in a surge in profits this year. Current forecasts suggest that Sky’s earnings per share will fall by 9.5% to 62p for the year ending 30 June. A further 7.3% decline is forecast for 2016/17.

One reason for this may be the short-term cost of reducing the group’s £6bn net debt, which is largely the result of Sky’s acquisition of Sky Deutschland and Sky Italia in 2014. Sky has always generated a lot of free cash flow, but reducing the group’s debt will still be a demanding challenge.

Given Sky’s high gearing and the lacklustre outlook for earnings growth, I’m tempted to tune in elsewhere. Sky’s forecast P/E of 16.5 and the firm’s 3.4% forecast dividend don’t seem like bargains to me.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Roland Head owns shares of GlaxoSmithKline. The Motley Fool UK has recommended GlaxoSmithKline and Sky. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Mature couple at the beach
Investing Articles

6 stocks that Fools have been buying!

Our Foolish freelancers are putting their money where their mouths are and buying these stocks in recent weeks.

Read more »

Black woman using loudspeaker to be heard
Investing Articles

I was right about the Barclays share price! Here’s what I think happens next

Jon Smith explains why he still feels the Barclays share price is undervalued and flags up why updates on its…

Read more »

Investing Articles

Where I’d start investing £8,000 in April 2024

Writer Ben McPoland highlights two areas of the stock market that he would target if he were to start investing…

Read more »

View of Tower Bridge in Autumn
Investing Articles

Ahead of the ISA deadline, here are 3 FTSE 100 stocks I’d consider

Jon Smith notes down some FTSE 100 stocks in sectors ranging from property to retail that he thinks could offer…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

Why I think Rolls-Royce shares will pay a dividend in 2024

Stephen Wright thinks Rolls-Royce shares are about to pay a dividend again. But he isn’t convinced this is something investors…

Read more »

Investing Articles

1 of the best UK shares to consider buying in April

Higher gold prices and a falling share price have put this FTSE 250 stock on Stephen Wright's list of UK…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

The market is wrong about this FTSE 250 stock. I’m buying it in April

Stephen Wright thinks investors should look past a 49% decline in earnings per share and consider investing in a FTSE…

Read more »

Black father and two young daughters dancing at home
Investing Articles

1 FTSE 250 stock I own, and 1 I’d love to buy

Our writer explains why she’s eyeing up this FTSE 250 growth phenomenon, and may buy more shares in this property…

Read more »